Background Radiation-induced cardiotoxicity poses a significant challenge in lung cancer
management because of the close anatomical proximity of the heart to the lungs …

Background: Radiotherapy-associated cardiac toxicity studies in patients with locally
advanced non–small cell lung cancer (NSCLC) have been limited by small sample size and …

Background Higher cardiac radiotherapy (RT) doses when treating lung cancer are
associated with worse overall survival (OS), although the direct association between cardiac …

Aims Cardiac disease is a dose-limiting toxicity in non-small cell lung cancer radiotherapy.
The dose to the heart base has been associated with poor survival in multiple institutional …

Background and purpose To assess associations between radiation dose/volume
parameters for cardiac subvolumes and different types of cardiac events in patients treated …

Background Radiotherapy may cause grade≥ 3 cardiac events, necessitating a better
understanding of risk factors. The potential predictive role of imaging biomarkers with …

Aims To assess the risk of cardiac toxicity following radical radiotherapy in advanced lung
cancer patients. Materials and methods Patients with a diagnosis of stage III non-small cell …

More than half of all patients with cancer receive radiation therapy. While radiation is a
critical component of cancer treatment for many malignancies, incidental cardiac radiation …

Background To maximize the likelihood of positive outcome in non-small-cell lung cancer
(NSCLC) survivors, potential benefits of treatment modalities have to be weighed against the …

Introduction Acute effects of incidental cardiac irradiation in patients treated for thoracic
cancer are not well characterized. We evaluated longitudinal changes in cardiac biomarkers …